Core K - Substance Use Research Core
Core K - Substance Use Research Core
批准号:
10197767
负责人:
Karsten Lunze
金额:
$22.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-01 至 2023-06-30
关键词:
AIDS preventionAccountingAcquired Immunodeficiency SyndromeAddressAdherenceApplications GrantsBasic ScienceBehavior TherapyBehavioral SciencesBiological TestingBostonCardiovascular DiseasesCaringCause of DeathChronic DiseaseClinicalClinical ResearchConsultationsConsumptionContinuity of Patient CareData AnalysesDevelopmentDisease ManagementDrug usageEcological momentary assessmentEnsureEpidemicEthical IssuesEthicsFinancial compensationFunctional disorderFundingGoalsHIVHIV InfectionsHeavy DrinkingImmunologicsInstitutionInstitutional Review BoardsInterventionInterviewKnowledgeLaboratoriesLeadershipLifeLiver diseasesLongitudinal StudiesMalignant NeoplasmsManualsManuscriptsMedicineMethodsMissionMobile Health ApplicationNational Institute on Alcohol Abuse and AlcoholismNeurocognitiveNeurokinin AOutcomeOutcome StudyPatient Self-ReportPharmacotherapyPopulationProtocols documentationPublic Health PracticePublicationsResearchResearch DesignResearch PersonnelResearch Project GrantsResourcesRiskRoleServicesSeveritiesSiteSmokingStructureTechniquesTestingTrainingTranslational ResearchTreatment outcomeUniversitiesViralVulnerable PopulationsWorkaddictionalcohol researchalcohol, tobacco, and other drug usebasecocaine usecomorbiditydisabilityinjection drug useinnovationmortality risksocial stigmasoundstimulant usesubstance usetooltransmission processtreatment disparity
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
Unhealthy substance use (SU) is a leading cause of death and disability in the US and a common comorbidity
of people living with HIV (PLWH), among whom it is consistently associated with delays to engagement in HIV
care, worse retention in care, lower ART adherence, and worse viral and immunologic outcomes. Therefore, HIV
research must use rigorous methods to account for SU in study designs and analyses and to test SU
interventions. The Substance Use Research Core (SURC) is an innovative and defining feature of the
Providence/Boston Center for AIDS Research (P/B CFAR) that will catalyze innovations in SU/HIV research and
strengthen the P/B CFAR's mission to address HIV in vulnerable populations. To support the development of
basic, clinical, and translational research that addresses the impact of SU on the HIV epidemic, the SURC has
the following Specific Aims: 1) To provide CFAR investigators expertise in developing research projects that
address gaps in SU/HIV priority issues both domestically and globally. The SURC will ensure that CFAR projects
appropriately consider and incorporate the impact of SU on study outcomes; connect SU investigators and HIV
investigators through formal and informal opportunities to develop collaborative projects; and work with CFAR
investigators to formulate innovative and scientifically sound SU/HIV research questions. 2) To support CFAR
investigators in the conduct of rigorous HIV research that takes SU into account. The SURC will provide services
to help investigators identify the most appropriate tools to assess consumption, severity, consequences and
associated stigma of SU as well as provide training on utilization of validated self-report scales, structured
interviews, laboratory and ecological momentary assessments, and biological tests of SU. The SURC has
expertise on SU pharmacotherapy, behavioral interventions, mobile health (mHealth) applications, and chronic
disease management. Core services in this realm will include SU intervention selection and training, fidelity
assessment techniques, intervention manuals, and adaptation to new populations. The SURC will also review
relevant IRB protocols and provide guidance on ethical issues of particular importance to SU research, such as
confidentiality protections and providing compensation to people actively using drugs. The services provided by
the SURC will ensure that CFAR investigators are optimally equipped to pursue research projects that consider
and address the major impact of SU on HIV prevention, the HIV Care Continuum, and HIV comorbidities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Community-engaged implementation strategies for acceptance interventions to improve access to care for people with HIV and injection drug use
-
批准号:10762655
-
项目类别:
-
资助金额:$8.9万
-
财政年份:2023
-
负责人:Karsten Lunze
-
依托单位:
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention"
-
批准号:10706554
-
项目类别:
-
资助金额:$64.81万
-
财政年份:2022
-
负责人:Karsten Lunze
-
依托单位:
Gabapentin to Reduce Alcohol and Improve Viral Load Suppression - Promoting "Treatment as Prevention"
-
批准号:10541347
-
项目类别:
-
资助金额:$73.85万
-
财政年份:2022
-
负责人:Karsten Lunze
-
依托单位:
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs
-
批准号:10199478
-
项目类别:
-
资助金额:$16.04万
-
财政年份:2018
-
负责人:Karsten Lunze
-
依托单位:
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs
-
批准号:9767759
-
项目类别:
-
资助金额:$24.78万
-
财政年份:2018
-
负责人:Karsten Lunze
-
依托单位:
Stigma, Risk Behaviors and Health Care among HIV-infected Russian People Who Inject Drugs
-
批准号:9982917
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2018
-
负责人:Karsten Lunze
-
依托单位:
Core K - Substance Use Research Core
-
批准号:10454399
-
项目类别:
-
资助金额:$22.49万
-
财政年份:1998
-
负责人:Karsten Lunze
-
依托单位:
海外基金